
About InvivoGen
InvivoGen is a Healthcare company based in San Diego (United States) founded in 1997 by Gerard Tiraby. It produces high-quality reagents for cell and molecular biology research. It operates on a B2B model. The company has 14 employees. Its focus areas include Biotechnology, Research Reagents and Molecular Biology. Its competitors include BioLife Solutions, RoosterBio and OriGene; 2 of its 3 listed competitors have raised funding.
Company details
InvivoGen, founded in 1997 in San Diego, United States, focuses on providing healthcare solutions, advancing biotech innovations, research reagents, and molecular biology. Produces high-quality reagents for cell and molecular biology research. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
- Headquarters San Diego, United States
- Employees 14
- Founders Gerard Tiraby
- SectorsHealthcare
- Phoneβ’β’β’β’ β’β’β’β’
- Website invivogen.com
- Social LinkedIn X Facebook
- Legal Name Invivogen
- Employee Count14
People of InvivoGen
2 people are tracked at InvivoGen (2 in leadership); the tracked headcount is 14.
| Name | Role | Group |
|---|---|---|
Gerard Tiraby | Founder | Leadership |
Eric Perouzel | Managing Director, Chairman | Leadership |
Complete people profiles for InvivoGen
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of InvivoGen
InvivoGen has 3 listed competitors in our database, 2 of them funded. They include BioLife Solutions, RoosterBio and OriGene.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| biolifesolutions.com | 1987 | Bothell, United States | 685 | Tissue hypothermic storage and cryopreservation freeze media are developed. | ||
| roosterbio.com | 2012 | Frederick, United States | $38.41M | 69 | Developer of human mesenchymal stem cells and extracellular vesicles | |
| origene.com | 1996 | Rockville, United States | $69.55M | 141 | Proteins, antibodies, and molecular tools are manufactured for research applications. |
Detailed competitors of InvivoGen
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of InvivoGen
Websites that share an audience with InvivoGen (invivogen.com).
Websites whose visitors overlap most with InvivoGen. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| takara-bio.com | 100% | 4K | #4,713,078 | View details | |
| ambergen.com | 100% | View details | |||
| shenandoah-bt.com | 100% | View details | |||
| markergene.com | 95% | View details | |||
| epigenomics.com | 94% | 2.4K | #6,675,395 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 35 similar websites and full traffic analytics for InvivoGen
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 35 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as InvivoGen (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Invivogen
Complete news archive for InvivoGen
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about InvivoGen
InvivoGen was founded in 1997.
InvivoGen is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
InvivoGen has 14 employees.
InvivoGen, founded in 1997 in San Diego, United States, focuses on providing healthcare solutions, advancing biotech innovations, research reagents, and molecular biology. Produces high-quality reagents for cell and molecular biology research. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
InvivoGen's top competitors include RoosterBio, BioLife Solutions and OriGene.
InvivoGen operates through Invivogen.
